Biosimilars Market Summary The global biosimilars market size was estimated at USD 33.92 million in 2024 and is projected to reach USD 151.58 million by 2033, growing at a CAGR of 18.27 percent from 2025 to 2033. The cost-effectiveness of biosimilar drugs and the prevalence of chronic disorders globally are major factors contributing to market growth. As patients and healthcare...

Modern eye care has been revolutionized by the integration of high-resolution imaging and precision surgical hardware. Within the clinical environment, devices names like Optical Coherence Tomography (OCT) scanners have become indispensable for diagnosing retinal conditions. These specific technologies allow for a non-invasive, cross-sectional view of the eye, facilitating early intervention...

In the high-stakes world of biological medicine, information is the most powerful tool. For a business to succeed in the biosimilars market, it needs more than just a good product; it needs a deep understanding of patent law, regulatory requirements, and the specific needs of the local market. The complexity of these medicines means that the "business of biosimilars" is fundamentally different...